Viewing Study NCT07285694


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2026-01-18 @ 9:41 PM
Study NCT ID: NCT07285694
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-16
First Post: 2025-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)
Sponsor: Arsenal Biosciences, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module